Literature DB >> 25261095

Cytomegalovirus shapes long-term immune reconstitution after allogeneic stem cell transplantation.

Raphael Itzykson1, Marie Robin2, Helene Moins-Teisserenc3, Marc Delord4, Marc Busson5, Aliénor Xhaard2, Flore Sicre de Fontebrune1, Régis Peffault de Latour2, Antoine Toubert3, Gérard Socié6.   

Abstract

Immune reconstitution after allogeneic stem cell transplantation is a dynamic and complex process depending on the recipient and donor characteristics, on the modalities of transplantation, and on the occurrence of graft-versus-host disease. Multivariate methods widely used for gene expression profiling can simultaneously analyze the patterns of a great number of biological variables on a heterogeneous set of patients. Here we use these methods on flow cytometry assessment of up to 25 lymphocyte populations to analyze the global pattern of long-term immune reconstitution after transplantation. Immune patterns were most distinct from healthy controls at six months, and had not yet fully recovered as long as two years after transplant. The two principal determinants of variability were linked to the balance of B and CD8(+) T cells and of natural killer and B cells, respectively. Recipient's cytomegalovirus serostatus, cytomegalovirus replication, and chronic graft-versus-host disease were the main factors shaping the immune pattern one year after transplant. We identified a complex signature of under- and over-representation of immune populations dictated by recipient's cytomegalovirus seropositivity. Finally, we identified dimensions of variance in immune patterns as significant predictors of long-term non-relapse mortality, independently of chronic graft-versus-host disease. Copyright© Ferrata Storti Foundation.

Entities:  

Mesh:

Year:  2014        PMID: 25261095      PMCID: PMC4281324          DOI: 10.3324/haematol.2014.113415

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  44 in total

Review 1.  Viral latency drives 'memory inflation': a unifying hypothesis linking two hallmarks of cytomegalovirus infection.

Authors:  Christof K Seckert; Marion Griessl; Julia K Büttner; Sabine Scheller; Christian O Simon; Kai A Kropp; Angélique Renzaho; Birgit Kühnapfel; Natascha K A Grzimek; Matthias J Reddehase
Journal:  Med Microbiol Immunol       Date:  2012-09-19       Impact factor: 3.402

2.  Diverse and heritable lineage imprinting of early haematopoietic progenitors.

Authors:  Shalin H Naik; Leïla Perié; Erwin Swart; Carmen Gerlach; Nienke van Rooij; Rob J de Boer; Ton N Schumacher
Journal:  Nature       Date:  2013-04-03       Impact factor: 49.962

3.  Immunosuppressive CD14+HLA-DRlow/neg IDO+ myeloid cells in patients following allogeneic hematopoietic stem cell transplantation.

Authors:  D Mougiakakos; R Jitschin; L von Bahr; I Poschke; R Gary; B Sundberg; A Gerbitz; P Ljungman; K Le Blanc
Journal:  Leukemia       Date:  2012-07-25       Impact factor: 11.528

4.  Long-term immune deficiency after allogeneic stem cell transplantation: B-cell deficiency is associated with late infections.

Authors:  Elise Corre; Maryvonnick Carmagnat; Marc Busson; Regis Peffault de Latour; Marie Robin; Patricia Ribaud; Antoine Toubert; Claire Rabian; Gerard Socié
Journal:  Haematologica       Date:  2010-02-04       Impact factor: 9.941

5.  Multiparameter single-cell profiling of human CD4+FOXP3+ regulatory T-cell populations in homeostatic conditions and during graft-versus-host disease.

Authors:  Shen Dong; Sylvie Maiella; Aliénor Xhaard; Yuanyu Pang; Lynn Wenandy; Jérome Larghero; Christophe Becavin; Arndt Benecke; Elisabetta Bianchi; Gérard Socié; Lars Rogge
Journal:  Blood       Date:  2013-07-01       Impact factor: 22.113

6.  CD19+CD5+ B cells and B1-like cells following allogeneic hematopoietic stem cell transplantation.

Authors:  Hélène Moins-Teisserenc; Marc Busson; Adel Herda; Sandrine Apete; Regis Peffault de Latour; Marie Robin; Aliénor Xhaard; Antoine Toubert; Gérard Socié
Journal:  Biol Blood Marrow Transplant       Date:  2013-03-16       Impact factor: 5.742

Review 7.  Enhancing T cell reconstitution after hematopoietic stem cell transplantation: a brief update of the latest trends.

Authors:  Johannes L Zakrzewski; Gabrielle L Goldberg; Odette M Smith; Marcel R M van den Brink
Journal:  Blood Cells Mol Dis       Date:  2007-10-01       Impact factor: 3.039

8.  CMV serostatus still has an important prognostic impact in de novo acute leukemia patients after allogeneic stem cell transplantation: a report from the Acute Leukemia Working Party of EBMT.

Authors:  Martin Schmidt-Hieber; Myriam Labopin; Dietrich Beelen; Liisa Volin; Gerhard Ehninger; Jürgen Finke; Gerard Socié; Rainer Schwerdtfeger; Nicolaus Kröger; Arnold Ganser; Dietger Niederwieser; Emmanuelle Polge; Igor W Blau; Mohamad Mohty
Journal:  Blood       Date:  2013-09-13       Impact factor: 22.113

9.  Relationship of reconstituted adaptive and innate cytomegalovirus (CMV)-specific immune responses with CMV viremia in hematopoietic stem cell transplant recipients.

Authors:  Michelle A Barron; Dexiang Gao; Kathryn L Springer; Julie A Patterson; Mark W Brunvand; Peter A McSweeney; Chang Zeng; Anna E Barón; Adriana Weinberg
Journal:  Clin Infect Dis       Date:  2009-12-15       Impact factor: 9.079

Review 10.  Why must T cells be cross-reactive?

Authors:  Andrew K Sewell
Journal:  Nat Rev Immunol       Date:  2012-09       Impact factor: 53.106

View more
  23 in total

Review 1.  Reconstitution of adaptive immunity after umbilical cord blood transplantation: impact on infectious complications.

Authors:  Sophie Servais; Muriel Hannon; Régis Peffault de Latour; Gérard Socie; Yves Beguin
Journal:  Stem Cell Investig       Date:  2017-05-25

2.  Genetic T-cell receptor diversity at 1 year following allogeneic hematopoietic stem cell transplantation.

Authors:  Stéphane Buhler; Florence Bettens; Carole Dantin; Sylvie Ferrari-Lacraz; Marc Ansari; Anne-Claire Mamez; Stavroula Masouridi-Levrat; Yves Chalandon; Jean Villard
Journal:  Leukemia       Date:  2019-11-26       Impact factor: 11.528

Review 3.  CMV-specific immune reconstitution following allogeneic stem cell transplantation.

Authors:  Emily Blyth; Barbara Withers; Leighton Clancy; David Gottlieb
Journal:  Virulence       Date:  2016-08-09       Impact factor: 5.882

4.  Robust CD4+ T-cell recovery in adults transplanted with cord blood and no antithymocyte globulin.

Authors:  Ioannis Politikos; Jessica A Lavery; Patrick Hilden; Christina Cho; Taylor Borrill; Molly A Maloy; Sergio A Giralt; Marcel R M van den Brink; Miguel-Angel Perales; Juliet N Barker
Journal:  Blood Adv       Date:  2020-01-14

5.  Allogeneic Hematopoietic Cell Transplantation in the Outpatient Setting.

Authors:  Noa Granot; Barry E Storer; Jason P Cooper; Mary E Flowers; Brenda M Sandmaier; Rainer Storb
Journal:  Biol Blood Marrow Transplant       Date:  2019-06-28       Impact factor: 5.742

Review 6.  National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Immune Dysregulation and Pathobiology Working Group Report.

Authors:  Juan Gea-Banacloche; Krishna V Komanduri; Paul Carpenter; Sophie Paczesny; Stefanie Sarantopoulos; Jo-Anne Young; Nahed El Kassar; Robert Q Le; Kirk R Schultz; Linda M Griffith; Bipin N Savani; John R Wingard
Journal:  Biol Blood Marrow Transplant       Date:  2016-10-14       Impact factor: 5.742

7.  Analysis of the Whole CDR3 T Cell Receptor Repertoire after Hematopoietic Stem Cell Transplantation in 2 Clinical Cohorts.

Authors:  Omid Shah; John S Tamaresis; Laura Jean Kenyon; Liwen Xu; Pingping Zheng; Puja Gupta; Krish Rangarajan; Stephanie Lee; Stephen Spellman; Sarah Nikiforow; James Zehnder; Everett H Meyer
Journal:  Biol Blood Marrow Transplant       Date:  2020-02-18       Impact factor: 5.742

8.  A novel immature natural killer cell subpopulation predicts relapse after cord blood transplantation.

Authors:  Li Li; Han Chen; David Marin; Yuanxin Xi; Qi Miao; Jiangxing Lv; Pinaki Prosad Banerjee; Hila Shaim; May Daher; Rafet Basar; Nobuhiko Imahashi; Juan Jimenez; Bingqian Hu; Rohtesh S Mehta; Lucila Nassif Kerbauy; Mecit Kaplan; Mayela Mendt; Gonca Ozcan; Elif Gokdemir; Mayra Hernandez Sanabria; Ye Li; Ken Chen; Jing Wang; Luis Muniz-Feliciano; Wei-Li Zhao; Richard E Champlin; Elizabeth J Shpall; Katayoun Rezvani
Journal:  Blood Adv       Date:  2019-12-10

9.  Origin and evolution of the T cell repertoire after posttransplantation cyclophosphamide.

Authors:  Christopher G Kanakry; David G Coffey; Andrea M H Towlerton; Ante Vulic; Barry E Storer; Jeffrey Chou; Cecilia C S Yeung; Christopher D Gocke; Harlan S Robins; Paul V O'Donnell; Leo Luznik; Edus H Warren
Journal:  JCI Insight       Date:  2016-04-21

10.  Comprehensive viromewide antibody responses by systematic epitope scanning after hematopoietic cell transplantation.

Authors:  Rachel A Bender Ignacio; Sayan Dasgupta; Terry Stevens-Ayers; Tomasz Kula; Joshua A Hill; Stephanie J Lee; Marco Mielcarek; Ann Duerr; Stephen J Elledge; Michael Boeckh
Journal:  Blood       Date:  2019-06-11       Impact factor: 25.476

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.